{"entity":{"type":"insider","cik":"0001736665","url":"/insider/0001736665","json_url":"/insider/0001736665.json","name":"BSOF Parallel Master Fund L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2021-08-03","last":"2021-10-08","span_basis":"filed_date"},"name_variants":[{"name":"BSOF Parallel Master Fund L.P.","source":"filing","n_filings":7,"first_seen":"2021-08-03","last_seen":"2021-10-08"}],"transactions":[{"id":4761258,"accession":"0000899243-21-039704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-039704","line_url":"/filing/0000899243-21-039704#line-1","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Inc; SCHWARZMAN STEPHEN A; BSOF Parallel Master Fund L.P.; Blackstone Holdings II L.P.; Blackstone Alternative Solutions L.L.C.; Blackstone Holdings I/II GP L.L.C.; Blackstone Holdings I L.P.; Blackstone Group Management L.L.C.; Blackstone Strategic Opportunity Associates L.L.C.","owner_display_name":"Blackstone Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-06","filed_date":"2021-10-08","scope":"insider"},{"id":4564107,"accession":"0000899243-21-039264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-039264","line_url":"/filing/0000899243-21-039264#line-2","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"BSOF Parallel Master Fund L.P.; Blackstone Alternative Solutions L.L.C.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Group Management L.L.C.; Blackstone Holdings I/II GP L.L.C.; Blackstone Holdings II L.P.; Blackstone Inc; SCHWARZMAN STEPHEN A; Blackstone Holdings I L.P.","owner_display_name":"BSOF Parallel Master Fund L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23946.0,"shares_display":"23,946","price_per_share":19.15,"price_display":"19.15","price_state":"stated","total_value":458565.9,"total_display":"458,565.90","total_whole":"458,566","shares_owned_after":400000.0,"shares_owned_after_display":"400,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-05","scope":"insider"},{"id":4564103,"accession":"0000899243-21-039264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-039264","line_url":"/filing/0000899243-21-039264#line-1","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"BSOF Parallel Master Fund L.P.; Blackstone Alternative Solutions L.L.C.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Group Management L.L.C.; Blackstone Holdings I/II GP L.L.C.; Blackstone Holdings II L.P.; Blackstone Inc; SCHWARZMAN STEPHEN A; Blackstone Holdings I L.P.","owner_display_name":"BSOF Parallel Master Fund L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22600.0,"shares_display":"22,600","price_per_share":19.13,"price_display":"19.13","price_state":"stated","total_value":432338.0,"total_display":"432,338.00","total_whole":"432,338","shares_owned_after":423946.0,"shares_owned_after_display":"423,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":4451472,"accession":"0000899243-21-034149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-034149","line_url":"/filing/0000899243-21-034149","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Group Management L.L.C.; Blackstone Holdings I/II GP L.L.C.; Blackstone Alternative Solutions L.L.C.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Holdings I L.P.; Blackstone Inc; SCHWARZMAN STEPHEN A; BSOF Parallel Master Fund L.P.; Blackstone Holdings II L.P.","owner_display_name":"Blackstone Group Management L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":352396.0,"shares_display":"352,396","price_per_share":19.002275394726386,"price_display":"19.00","price_state":"stated","total_value":6696325.84,"total_display":"6,696,325.84","total_whole":"6,696,326","shares_owned_after":447317.0,"shares_owned_after_display":"447,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider","n_lines":2},{"id":5395607,"accession":"0000899243-21-033841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-033841","line_url":"/filing/0000899243-21-033841#line-1","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Inc; SCHWARZMAN STEPHEN A; Blackstone Holdings II L.P.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Group Management L.L.C.; Blackstone Holdings I L.P.; Blackstone Holdings I/II GP L.L.C.; Blackstone Alternative Solutions L.L.C.; BSOF Parallel Master Fund L.P.","owner_display_name":"Blackstone Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.88,"price_display":"15.88","price_state":"stated","total_value":47640.0,"total_display":"47,640.00","total_whole":"47,640","shares_owned_after":798942.0,"shares_owned_after_display":"798,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-20","scope":"insider"},{"id":4205000,"accession":"0000899243-21-032969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-032969","line_url":"/filing/0000899243-21-032969#line-2","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Group Management L.L.C.; Blackstone Inc; SCHWARZMAN STEPHEN A; Blackstone Alternative Solutions L.L.C.; BSOF Parallel Master Fund L.P.; Blackstone Holdings II L.P.; Blackstone Holdings I/II GP L.L.C.; Blackstone Holdings I L.P.; Blackstone Strategic Opportunity Associates L.L.C.","owner_display_name":"Blackstone Group Management L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10060.0,"shares_display":"10,060","price_per_share":13.92,"price_display":"13.92","price_state":"stated","total_value":140035.2,"total_display":"140,035.20","total_whole":"140,035","shares_owned_after":801942.0,"shares_owned_after_display":"801,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-13","scope":"insider"},{"id":4204996,"accession":"0000899243-21-032969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-032969","line_url":"/filing/0000899243-21-032969#line-1","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Group Management L.L.C.; Blackstone Inc; SCHWARZMAN STEPHEN A; Blackstone Alternative Solutions L.L.C.; BSOF Parallel Master Fund L.P.; Blackstone Holdings II L.P.; Blackstone Holdings I/II GP L.L.C.; Blackstone Holdings I L.P.; Blackstone Strategic Opportunity Associates L.L.C.","owner_display_name":"Blackstone Group Management L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17222.0,"shares_display":"17,222","price_per_share":15.03,"price_display":"15.03","price_state":"stated","total_value":258846.66,"total_display":"258,846.66","total_whole":"258,847","shares_owned_after":812002.0,"shares_owned_after_display":"812,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-13","scope":"insider"},{"id":5364303,"accession":"0000899243-21-031824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-031824","line_url":"/filing/0000899243-21-031824#line-1","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"SCHWARZMAN STEPHEN A; BSOF Parallel Master Fund L.P.; Blackstone Alternative Solutions L.L.C.; Blackstone Group Management L.L.C.; Blackstone Holdings II L.P.; Blackstone Holdings I/II GP L.L.C.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Group Inc; Blackstone Holdings I L.P.","owner_display_name":"SCHWARZMAN STEPHEN A","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22300.0,"shares_display":"22,300","price_per_share":14.99,"price_display":"14.99","price_state":"stated","total_value":334277.0,"total_display":"334,277.00","total_whole":"334,277","shares_owned_after":829224.0,"shares_owned_after_display":"829,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":4509294,"accession":"0000899243-21-031302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-031302","line_url":"/filing/0000899243-21-031302#line-2","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Group Inc; SCHWARZMAN STEPHEN A; BSOF Parallel Master Fund L.P.; Blackstone Alternative Solutions L.L.C.; Blackstone Holdings II L.P.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Group Management L.L.C.; Blackstone Holdings I L.P.; Blackstone Holdings I/II GP L.L.C.","owner_display_name":"Blackstone Group Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":15.78,"price_display":"15.78","price_state":"stated","total_value":631200.0,"total_display":"631,200.00","total_whole":"631,200","shares_owned_after":851524.0,"shares_owned_after_display":"851,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":4509290,"accession":"0000899243-21-031302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-031302","line_url":"/filing/0000899243-21-031302#line-1","is_derivative":false,"issuer_cik":"0001070844","issuer_name":"Praxis Precision Medicines, Inc.","issuer_ticker":"PRAX","issuer_name_source":null,"issuer_url":"/issuer/0001070844","owner_cik":null,"owner_name":"Blackstone Group Inc; SCHWARZMAN STEPHEN A; BSOF Parallel Master Fund L.P.; Blackstone Alternative Solutions L.L.C.; Blackstone Holdings II L.P.; Blackstone Strategic Opportunity Associates L.L.C.; Blackstone Group Management L.L.C.; Blackstone Holdings I L.P.; Blackstone Holdings I/II GP L.L.C.","owner_display_name":"Blackstone Group Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15854.0,"shares_display":"15,854","price_per_share":15.68,"price_display":"15.68","price_state":"stated","total_value":248590.72,"total_display":"248,590.72","total_whole":"248,591","shares_owned_after":891524.0,"shares_owned_after_display":"891,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-30","filed_date":"2021-08-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689548","name":"Praxis Precision Medicines, Inc.","url":"/issuer/0001689548","role":"Ten percent owner","n_filings":7,"first_seen":"2021-08-03","last_seen":"2021-10-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001736665","retrieved_at":"2026-08-22T20:25:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}